On November 27, according tomedia reports, South Africa’s Health Minister Zweli Mkhize publicly announced that a new type of HIV drug would be introduced on December 1st (World AIDS Day). The new drug, called TLD, is a combination of three antiretroviral drugs: tenovovir, ramifeddine and dolutegravir. South African officials say it is more advanced, less side-effects and cheaper than current HIV drugs.
Sandile Buthelezi, PhD, of the South African AIDS Commission, said: “The side effects of the new drug are minimal and all patients are well tolerated. Second, the drug works particularly quickly to suppress viruses in the blood. The third is sometimes its price, the price is very high. Another benefit is that the new drug does not make the virus resistant, and it is still very resistant. “
Shadil also said South Africa would work with foreign agencies to buy the drug at a certain price. It will also be given to some manufacturers to produce, so that other developed countries can also buy it.
According to the Global Health Initiative, TLD can reduce the average annual cost of medicines for people living with AIDS in South Africa to $75 (about 527 yuan).